Wave Life Sciences Ltd. WVE

Updated: 15 Jun 2026

NASDAQ | Biotech | RNA medicines and genetic therapies

No signal published yet

We already track Wave Life Sciences and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Wave Life Sciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
RNA medicines and genetic therapies
We're already tracking Wave Life Sciences Ltd. — here are the latest events we've registered

Recent News

  • On May 18, 2026, the company announced positive interim data from the RestorAATion-2 trial for WVE-006, demonstrating successful RNA editing in patients with alpha-1 antitrypsin deficiency. Earlier in 2026, Wave regained full global rights to the WVE-006 program from GSK.

What Firelda Watch includes for Wave Life Sciences Ltd.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Wave Life Sciences Ltd. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Bioarctic
BIOA B
BUY
Recipharm
RECI B
NEUTRAL
Viatris Inc.
VTRS
HOLD
Xbrane Biopharma AB (publ)
XBRANE
HOLD
AstraZeneca PLC
AZN
HOLD

Biotech

More companies in this sector

Want to follow Wave Life Sciences Ltd.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Wave Life Sciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Wave Life Sciences Ltd. WVE
Wave Life Sciences — follow and we'll monitor it
Follow Wave Life Sciences free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.